CD1d

Natural killer T cell activation increases iNOS⁺CD206^- M1 macrophage and controls the growth of solid tumor
Sourav Paul, Sushanta Chhatar, Amrita Mishra, Girdhari Lal

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 208; DOI: 10.1186/s40425-019-0697-7
iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine
Stéphanie Corgnac, Rachel Perret, Lianjun Zhang, Jean-Pierre Mach, Pedro Romero, Alena Donda

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 39; DOI: 10.1186/s40425-014-0039-8
Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes
Karsten A Pilones, Joseph Aryankalayil, James S Babb, Sandra Demaria

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 37; DOI: 10.1186/s40425-014-0037-x

Main menu